Ramucirumab Improves Survival in Poor-Prognosis HCC Ramucirumab Improves Survival in Poor-Prognosis HCC

Patients with hepatocellular carcinoma who have high levels of a protein linked to a poor prognosis derive a significant survival benefit with ramucirumab, the results of a pooled analysis reveal.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news